Literature DB >> 18030475

[Amniotic membrane transplantation. An indispensable therapy option for persistent corneal epithelial defects].

B Seitz1.   

Abstract

Nowadays, cryopreserved amniotic membrane transplantation (AMT) is omnipresent in the therapy of persistent corneal epithelial defects. With persistent corneal ulcers AMT should be considered early, to avoid keratoplasty à chaud or even a conjunctival flap. A differentiated microsurgical technique results in different integration patterns of AM into the human cornea. The sandwich technique seems to have advantages in contrast to the solitary graft or patch techniques with respect to primary success and recurrence rate. Corneal infections are extremely rare after AMT, but may happen. Postoperatively, phosphate-containing eye drops should not be used to avoid corneal calcification. AMT appears to have a great variety of merits before, instead of, during, or even after keratoplasty. The consequent systemic therapy of underlying diseases is absolutely indispensable for durable success of AMT.

Entities:  

Mesh:

Year:  2007        PMID: 18030475     DOI: 10.1007/s00347-007-1661-3

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  19 in total

Review 1.  [Reconstruction of the conjunctival and corneal surface. Transplantation of amnionic membrane].

Authors:  D Meller; S C Tseng
Journal:  Ophthalmologe       Date:  1998-12       Impact factor: 1.059

2.  [Autologous serum for otherwise therapy resistant corneal epithelial defects - Prospective report on the first 70 eyes].

Authors:  R Ferreira de Souza; F E Kruse; B Seitz
Journal:  Klin Monbl Augenheilkd       Date:  2001-11       Impact factor: 0.700

3.  Amniotic membrane inlay and overlay grafting for corneal epithelial defects and stromal ulcers.

Authors:  E Letko; S U Stechschulte; K R Kenyon; N Sadeq; T R Romero; C M Samson; Q D Nguyen; S L Harper; J D Primack; D T Azar; M Gruterich; C H Dohlman; S Baltatzis; C S Foster
Journal:  Arch Ophthalmol       Date:  2001-05

4.  Immunogenicity of human amniotic membrane in experimental xenotransplantation.

Authors:  M Kubo; Y Sonoda; R Muramatsu; M Usui
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-06       Impact factor: 4.799

5.  Histopathology and ultrastructure of human corneas after amniotic membrane transplantation.

Authors:  Berthold Seitz; Miklós D Resch; Ursula Schlötzer-Schrehardt; Carmen Hofmann-Rummelt; Renate Sauer; Friedrich E Kruse
Journal:  Arch Ophthalmol       Date:  2006-10

6.  Multilayered amniotic membrane transplantation for severe ulceration of the cornea and sclera.

Authors:  K Hanada; J Shimazaki; S Shimmura; K Tsubota
Journal:  Am J Ophthalmol       Date:  2001-03       Impact factor: 5.258

7.  Ex vivo preservation and expansion of human limbal epithelial stem cells on amniotic membrane cultures.

Authors:  D Meller; R T F Pires; S C G Tseng
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

8.  Cryopreserved human amniotic membrane for ocular surface reconstruction.

Authors:  F E Kruse; A M Joussen; K Rohrschneider; L You; B Sinn; J Baumann; H E Völcker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2000-01       Impact factor: 3.117

9.  Corneal calcification after amniotic membrane transplantation.

Authors:  S B Anderson; R Ferreira de Souza; C Hofmann-Rummelt; B Seitz
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

10.  Management of acute ulcerative and necrotising herpes simplex and zoster keratitis with amniotic membrane transplantation.

Authors:  A Heiligenhaus; H Li; E E Hernandez Galindo; J M Koch; K-P Steuhl; D Meller
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

View more
  7 in total

1.  [Chemical and thermal eye burns. Conservatíve and surgical options of a stage-dependent therapy].

Authors:  H G Struck; N F Schrage
Journal:  Ophthalmologe       Date:  2011-10       Impact factor: 1.059

Review 2.  Amniotic membrane transplantation in the human eye.

Authors:  Daniel Meller; Mikk Pauklin; Henning Thomasen; Henrike Westekemper; Klaus-Peter Steuhl
Journal:  Dtsch Arztebl Int       Date:  2011-04-08       Impact factor: 5.594

Review 3.  [Current and experimental treatment approaches for neurotrophic keratopathy].

Authors:  J Alder; S Mertsch; J Menzel-Severing; G Geerling
Journal:  Ophthalmologe       Date:  2019-02       Impact factor: 1.059

Review 4.  New Therapeutic Perceptions in a Patient with Complicated Herpes Simplex Virus 1 Keratitis: A Case Report and Review of the Literature.

Authors:  Dimitrios Kalogeropoulos; Aliki Geka; Konstantinos Malamos; Maria Kanari; Chris Kalogeropoulos
Journal:  Am J Case Rep       Date:  2017-12-27

5.  Incidence, prevalence, and outcome of moderate to severe neurotrophic keratopathy in a German tertiary referral center from 2013 to 2017.

Authors:  Mathias Roth; Sebastian Dierse; Jan Alder; Christoph Holtmann; Gerd Geerling
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-01-06       Impact factor: 3.535

6.  New clinical application of amniotic membrane transplant for ocular surface disease.

Authors:  A Gheorghe; M Pop; M Burcea; M Serban
Journal:  J Med Life       Date:  2016 Apr-Jun

7.  High-resolution optical coherence tomography in a case of descemetocele managed with amniotic membrane transplantation.

Authors:  Nilufer Sultana; Sunita Chaurasia; Muralidhar Ramappa
Journal:  Indian J Ophthalmol       Date:  2018-02       Impact factor: 1.848

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.